Literature DB >> 21826679

Regional body composition and functional impairment in patients with myotonic dystrophy.

Lelia Pruna1, Jerome Chatelin, Veronique Pascal-Vigneron, Pierre Kaminsky.   

Abstract

INTRODUCTION: In this study we determined regional body composition in myotonic dystrophy (DM1) and able-bodied controls and evaluated the relationship between fat and lean tissue mass and functional impairment in DM1 patients.
METHODS: Dual-energy X-ray absorptiometry (DEXA) was used to obtain regional measurements of fat-free mass index (FFMI) and fat mass index (FMI) in 48 DM1 and anthropometrically matched control pairs.
RESULTS: DM1 patients had lower regional FFMI and higher FMI than controls (P < 0.01-0.001). In DM1 patients, total FMI increased significantly with increased muscular disability rating, decreased motor function measurement, and with both decreasing vital capacity and total lung capacity. Hypertriglyceridemia correlated with increasing FMI.
CONCLUSIONS: Regional FFMI is decreased in DM1, whereas FMI is underestimated by body mass index and is negatively correlated with patients' functional capacity. DEXA may provide valuable supporting evidence in the management of DM1.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21826679     DOI: 10.1002/mus.22099

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  9 in total

1.  Body composition in Spinocerebellar ataxia type 3 and 10 patients: Comparative study with control group.

Authors:  Christiane de M B Almeida Leite; Maria Eliana M Schieferdecker; Caroline Frehner; Renato P Munhoz; Tetsuo Ashizawa; Hélio A G Teive
Journal:  Nutr Neurosci       Date:  2018-05-07       Impact factor: 4.994

2.  Myotonic dystrophy health index: Correlations with clinical tests and patient function.

Authors:  Chad Heatwole; Rita Bode; Nicholas E Johnson; Jeanne Dekdebrun; Nuran Dilek; Katy Eichinger; James E Hilbert; Eric Logigian; Elizabeth Luebbe; William Martens; Michael P Mcdermott; Shree Pandya; Araya Puwanant; Nan Rothrock; Charles Thornton; Barbara G Vickrey; David Victorson; Richard T Moxley
Journal:  Muscle Nerve       Date:  2015-12-29       Impact factor: 3.217

3.  Sarcopenia and sarcopenic obesity in patients with muscular dystrophy.

Authors:  Luciano Merlini; Alessandro Vagheggini; Daniela Cocchi
Journal:  Front Aging Neurosci       Date:  2014-10-07       Impact factor: 5.750

4.  Overweight Is an Independent Risk Factor for Reduced Lung Volumes in Myotonic Dystrophy Type 1.

Authors:  Charlotte G W Seijger; Gea Drost; Joram M Posma; Baziel G M van Engelen; Yvonne F Heijdra
Journal:  PLoS One       Date:  2016-03-25       Impact factor: 3.240

5.  Circulating Irisin Is Reduced in Male Patients with Type 1 and Type 2 Myotonic Dystrophies.

Authors:  Elena Dozio; Elena Passeri; Rosanna Cardani; Stefano Benedini; Carmen Aresta; Rea Valaperta; Massimiliano Corsi Romanelli; Giovanni Meola; Valeria Sansone; Sabrina Corbetta
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-14       Impact factor: 5.555

6.  Metabolic impairments in patients with myotonic dystrophy type 2.

Authors:  Milorad Vujnic; Stojan Peric; Zeljka Calic; Natasa Benovic; Tanja Nisic; Jovan Pesovic; Dusanka Savic-Pavicevic; Vidosava Rakocevic-Stojanovic
Journal:  Acta Myol       Date:  2018-12-01

Review 7.  Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1.

Authors:  Sylvia Nieuwenhuis; Kees Okkersen; Joanna Widomska; Paul Blom; Peter A C 't Hoen; Baziel van Engelen; Jeffrey C Glennon
Journal:  Front Neurol       Date:  2019-11-26       Impact factor: 4.003

8.  Body composition, muscle strength, and physical function of patients with Bethlem myopathy and Ullrich congenital muscular dystrophy.

Authors:  Maria Teresa Miscione; Francesca Bruno; Claudio Ripamonti; Giuliana Nervuti; Riccardo Orsini; Cesare Faldini; Massimo Pellegrini; Daniela Cocchi; Luciano Merlini
Journal:  ScientificWorldJournal       Date:  2013-09-12

9.  Association of Body Composition, Physical Functioning, and Protein Intake in Adult Patients With Mitochondrial Diseases.

Authors:  Heidi E E Zweers; Valentine Bordier; Jeanne In 't Hulst; Mirian C H Janssen; Geert J A Wanten; Susanne Leij-Halfwerk
Journal:  JPEN J Parenter Enteral Nutr       Date:  2020-03-19       Impact factor: 4.016

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.